SCHEMBL2895286

SCHEMBL2895286

CC(C)N(C(=N)OC(C)(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29985339 0.84
SCHEMBL31524055 0.84
SCHEMBL29149690 0.76 TSHR (0.30)
SCHEMBL21811860 0.70
SCHEMBL12261426 0.70 HDAC6 (0.36)
SCHEMBL9825491 0.69 TSHR (0.33)
SCHEMBL16223205 0.65 ALDH1A1 (0.37)
SCHEMBL9393135 0.65 ALDH1A1 (0.32)
SCHEMBL22186495 0.63 KMT2A (0.33)
SCHEMBL3869449 0.62 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250152658-A1 CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA MERCK SHARP & DOHME LLC (US) 2025-05-15 US disclosed
EP-4441070-A1 MODIFIED AMATOXINS AND USES THEREOF The University of British Columbia (CA) 2024-10-09 EP disclosed
CN-112135830-B Oxo-substituted compounds 住友制药株式会社 2024-06-14 CN disclosed
EP-4346898-A1 METHODS FOR INHIBITING RAS Revolution Medicines, Inc. (US) 2024-04-10 EP disclosed
US-11739101-B2 Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof NURIX THERAPEUTICS, INC. (US) 2023-08-29 US disclosed
WO-2023097407-A1 MODIFIED AMATOXINS AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-06-08 WO disclosed
CN-116018345-A Novel heterocyclic compounds 株式会社棱镜生物实验室 2023-04-25 CN disclosed
US-11519859-B2 Rhodol-based thallium sensors for high-throughput screening of potassium channels VANDERBILT UNIVERSITY (US) 2022-12-06 US disclosed
WO-2022251292-A1 METHODS FOR INHIBITING RAS Revolution Medicines, Inc. (US) 2022-12-01 WO disclosed
WO-2022186273-A1 RADIOACTIVE COMPOUND 国立大学法人千葉大学 2022-09-09 WO disclosed
US-4211703-A CHEMICAL INTERMEDIATES FOR CEPHALOSPORINS SMITHKLINE CORPORATION (US) 1980-07-08 US disclosed
US-4189573-A CHEMICAL INTERMEDIATES SMITHKLINE CORPORATION (US) 1980-02-19 US disclosed
US-4159373-A 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins SMITHKLINE CORPORATION (US) 1979-06-26 US disclosed
US-4140694-A BACTERICIDES SMITHKLINE CORPORATION (US) 1979-02-20 US disclosed
US-4139701-A BACTERICIDES SMITHKLINE CORPORATION (US) 1979-02-13 US disclosed
US-4118490-A ANTIBACTERIAL ACTIVITY SMITHKLINE CORPORATION (US) 1978-10-03 US disclosed
US-4112086-A BACTERICIDE SMITHKLINE CORPORATION (US) 1978-09-05 US disclosed
US-4101656-A 7β-Acylamino-3-(alkanesulfonamidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them SMITHKLINE CORPORATION (US) 1978-07-18 US disclosed
US-4093723-A ANTIBIOTICS SMITHKLINE CORPORATION (US) 1978-06-06 US disclosed
US-4048311-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1977-09-13 US disclosed